Randomized, controlled trial of recombinant human interleukin‐11 in patients with active Crohn's disease - Concepedia

Concepedia

Publication | Open Access

Randomized, controlled trial of recombinant human interleukin‐11 in patients with active Crohn's disease

DOI Full Paper Access

139

Citations

22

References

2002

Year

Bruce E. Sands, Barry Winston, Bruce Salzberg, Michael Safdi, Charles F. Barish, Lawrence D. Wruble, Robert A. Wilkins, Mark Shapiro, Ulrich Schwertschlag

Alimentary Pharmacology & Therapeutics

Abstract

Weekly subcutaneous injection with rhIL-11 15 microg/kg is safe and effective in inducing remission in a subset of patients with active Crohn's disease.

References

	Year	Citations
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. William R. Best, Jack M. Becktel, John W. Singleton, PubMed	1976	3.2K
A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease Stephan R. Targan, Stephen B. Hanauer, Sander J. H. van Deventer, New England Journal of Medicine	1997	3.1K
Development of a Crohn's Disease Activity Index William R. Best, Jack M. Becktel, John W. Singleton, Gastroenterology Functional Gastrointestinal DisorderDisease Activity IndexGastroenterologyUlcerative ColitisEpidemiology	1976	3.1K
A New Measure of Health Status for Clinical Trials in Inflammatory Bowel Disease Alba Mitchell, E. Jan Irvine, Joel Singer, Gastroenterology EpidemiologyFunctional Gastrointestinal DisorderNew MeasureClinical EpidemiologyGastroenterology	1989	1.2K
A new measure of health status for clinical trials in inflammatory bowel disease Gordon Guyatt, Alba Mitchell, E. Jan Irvine, Gastroenterology EpidemiologyFunctional Gastrointestinal DisorderNew MeasureClinical EpidemiologyGastroenterology	1989	732
Interleukin-11: Review of Molecular, Cell Biology, and Clinical Use Xunxiang Du, David A. Williams Blood	1997	389
Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production William L. Trepicchio, M Bozza, G Pedneault, The Journal of Immunology	1996	288
Expression of class II molecules on intestinal epithelial cells in humans Lloyd Mayer, D Eisenhardt, Peter Salomon, Gastroenterology Class Ii MoleculesGastroenterologyPathologyIntestinal Epithelial CellsDigestive Tract	1991	279
Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease Bruce E. Sands, Simmy Bank, Charles A. Sninsky, Gastroenterology InflammationAutoimmune DiseaseMucosal ImmunologyPreliminary EvaluationImmunology	1999	205
Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn's disease Andreas Stallmach, Detlef Schuppan, Hans H. Riese, Gastroenterology InflammationFibrosisImmunologyPathologyUlcerative Colitis	1992	186

Page 1